ISRCTN93856392
Active, Not Recruiting
N/A
A randomized controlled multi-centre trial investigating the effectiveness and safety of a wilderness program on the mental and physical well-being of childhood, adolescent and young adult cancer survivors
Mid Sweden University0 sites150 target enrollmentJanuary 25, 2024
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mid Sweden University
- Enrollment
- 150
- Status
- Active, Not Recruiting
- Last Updated
- last year
Overview
Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38772886/ (added 22/05/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Current inclusion criteria as of 15/04/2024:
- •1\. Adolescents and young adults (AYA) aged 16\-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood
- •2\. To be able to walk 2 km a day (walking aids or assistance from another person is permitted)
- •3\. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs.
- •4\. Prior experience with outdoor activities is not required for participation
- •Previous inclusion criteria:
- •1\. Adolescents and young adults (AYA) aged 16\-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood
- •2\. To be able to walk 2 km without pausing (walking aids or assistance from another person is permitted)
- •3\. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs.
- •4\. Prior experience with outdoor activities is not required for participation
Exclusion Criteria
- •1\. Active cancer treatment for which participation in the study can involve unwanted risks as evaluated by the treating physician/oncologist
- •2\. A medical condition that prevents safe travel to, or participation in the program
- •3\. Not willing to be randomly assigned
- •4\. Previous participation in the WAYA 1 study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
Autologous stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing-remitting multiple sclerosisRelapsing-remitting multiple sclerosisNervous System DiseasesMultiple sclerosisISRCTN88667898Sheffield Teaching Hospitals NHS Foundation Trust198
Active, Not Recruiting
N/A
SURECAN: Survivors rehabilitation evaluation after cancerISRCTN67900293Queen Mary University of London344
Active, Not Recruiting
Phase 2
Effects of external trigeminal nerve stimulation in ADHD and mechanisms of actioISRCTN82129325King's College London150
Completed
N/A
Cluster randomised trial to evaluate an intervention for depressed HIV-positive women in the perinatal period, to enhance child development and reduce maternal depressioPerinatal depression in women with HIV infectionMental and Behavioural DisordersISRCTN11284870The University of Oxford320
Completed
N/A
The impact of pausing BTKi therapy and responsiveness of vaccination in blood cancer patients: A randomised controlled study – the IMPROVE studyChronic lymphocytic leukaemiaCancerISRCTN14197181niversity of Birmingham99